- recruitingPhase III and phase IV (Integrated)
Clinical efficacy and safety of sequential therapy with cryotherapy and topical tirbanibulin 1% in actinic keratoses in transplant recipients: a randomised clinical trial.
This study looks at a skin condition called actinic keratosis in people who have had organ transplants. It compares a treatment that combines freezing therapy with a cream called Klisyri to freezing therapy alone, to see which is better at clearing these skin spots.
Spain - recruitingTherapeutic exploratory (Phase II)
Double-blind, Placebo-Controlled, Randomized Exploratory Trial: Topical VDA-1102 Ointment in Rapidly Proliferating Actinic Keratosis
This study tests a new medicated skin ointment called VDA-1102 for actinic keratosis. Actinic keratosis causes rough, sun-damaged patches on the skin that could turn into skin cancer. Researchers want to see if applying this ointment for 12 weeks clears these fast-growing spots better than a dummy cream.
Germany - recruitingHuman Pharmacology (Phase I)- Other
A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED PHASE I TRIAL TO INVESTIGATE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE ASCENDING TOPICAL DOSES OF GZ21T IN HEALTHY VOLUNTEERS
This early-stage study is testing a new skin treatment, GZ21T, for sun-damaged skin (actinic keratosis). We want to find out if it's safe, how much of it gets into the body, and if people can tolerate different doses. Healthy volunteers are needed for this research.
Sweden - recruitingPhase III/IV
A study to evaluate Adex Gel in the treatment of actinic keratosis
This UK study looks at how well Adex Gel works for actinic keratosis, which causes rough patches on sun-damaged skin. Around 65 adults will apply the gel three times a day for 12 weeks. Doctors at local GP surgeries will check their skin over four visits to see if it improves.
United Kingdom · England